No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: "the cure may be worse than the disease")
- PMID: 11191930
- DOI: 10.1016/s0987-7053(00)00238-0
No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: "the cure may be worse than the disease")
Abstract
Nonconvulsive status epilepticus (NCSE) is characterized by a cognitive or behavioral change which lasts for at least 30 minutes, with EEG evidence of seizures. Although there is little argument that generalized nonconvulsive status epilepticus (GNSE) does not cause lasting deficits, there is still debate regarding the morbidity of complex partial status epilepticus (CPSE). Because the EEG is used for diagnosis, a strong argument can be made that NCSE is significantly under-recognized and diagnosed. Furthermore, since the documented cases of permanent neurologic sequelae are few, the potential permanent morbidity from CPSE may be significantly exaggerated. The literature indicates that comatose patients have a poor prognosis largely as a result of comorbid conditions and coma, whereas lightly obtunded or slightly confused patients with NCSE have little or no sequelae. Patients with NCSE may suffer (hypotension and respiratory suppression) from iatrogenic 'aggressive' treatment with intravenous anti-epileptic drugs (IV-AEDs), and the findings in the literature indicate that subjects treated with benzodiazepines may have a worse prognosis. The clinician must balance the potential but rare neurologic morbidity associated with NCSE against the not infrequent morbidity caused by IV-AEDs. Better stratification of the level of consciousness and comorbid conditions is needed when evaluating outcomes so as to clearly distinguish among the deficits due to: comorbid conditions; the effects of treatment and the effects of status epilepticus (SE) proper.
Similar articles
-
Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity.J Clin Neurophysiol. 1999 Jul;16(4):341-52; discussion 353. doi: 10.1097/00004691-199907000-00006. J Clin Neurophysiol. 1999. PMID: 10478707 Review.
-
Prognosis in nonconvulsive status epilepticus.Epileptic Disord. 2000 Dec;2(4):185-93. Epileptic Disord. 2000. PMID: 11174148 Review.
-
Complex partial status epilepticus accompanied by serious morbidity and mortality.Neurology. 1995 Aug;45(8):1499-504. doi: 10.1212/wnl.45.8.1499. Neurology. 1995. PMID: 7644048
-
Evidence against permanent neurologic damage from nonconvulsive status epilepticus.J Clin Neurophysiol. 1999 Jul;16(4):323-31; discussion 353. doi: 10.1097/00004691-199907000-00004. J Clin Neurophysiol. 1999. PMID: 10478705 Review.
-
Intravenous valproate treatment of generalized nonconvulsive status epilepticus.Clin Electroencephalogr. 1999 Jan;30(1):1-4. doi: 10.1177/155005949903000104. Clin Electroencephalogr. 1999. PMID: 9891183
Cited by
-
Successful Use of Therapeutic Hypothermia for Refractory Nonconvulsive Status Epilepticus.J Epilepsy Res. 2017 Dec 31;7(2):109-114. doi: 10.14581/jer.17017. eCollection 2017 Dec. J Epilepsy Res. 2017. PMID: 29344469 Free PMC article.
-
Management of refractory status epilepticus in adults: still more questions than answers.Lancet Neurol. 2011 Oct;10(10):922-30. doi: 10.1016/S1474-4422(11)70187-9. Lancet Neurol. 2011. PMID: 21939901 Free PMC article. Review.
-
Outcomes of patients with altered level of consciousness and abnormal electroencephalogram: A retrospective cohort study.PLoS One. 2017 Sep 8;12(9):e0184050. doi: 10.1371/journal.pone.0184050. eCollection 2017. PLoS One. 2017. PMID: 28886073 Free PMC article.
-
Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus.J Intensive Care. 2017 Aug 8;5:54. doi: 10.1186/s40560-017-0248-6. eCollection 2017. J Intensive Care. 2017. PMID: 28808577 Free PMC article.
-
Treatment options in the management of status epilepticus.Curr Treat Options Neurol. 2010 Mar;12(2):100-12. doi: 10.1007/s11940-010-0060-2. Curr Treat Options Neurol. 2010. PMID: 20842574
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources